The 3rd annual INTERFACE HEALTH CHALLENGE X 2017 (#IHCX2017 competition seeks to find the world’s most innovative digital health start-ups.

This year CAAP companies KomodoOpenLab and KE2 Technologies have made it to the Top 10, guaranteeing a cash prize and putting them in contention for the $40K 1st Prize.

CAAP company SensOR Medical's ForceFilm technology, a thin add-on for minimally invasive surgical (MIS) instruments that provides surgeons with a digital sense of touch to help improve surgical safety, was selected as the Canadian James Dyson Award winner. SensOR will receive $3,400 toward ForceFilm’s development.

SensOR will now enter the International competition, where it will go up against other national winners for the ultimate $50,000 prize.

Pre-CAAP Company Trexo Robotics is featured in the September 6 edition of the Daily Mail UK.

MedStack and Zensurance recently announced a partnership that will bring competitive cyber-liability insurance packages to MedStack customers. Digital health companies on MedStack's platform meet the highest levels of security and stability, qualifying them for exclusive cybersecurity insurance packages from Zensurance.

Therapure Biopharma Inc. today announced that a joint venture between 3SBio Inc., a leading global biotechnology company, and CPE Funds has entered into an agreement to acquire Therapure’s contract development and manufacturing (CDMO) business and certain rights to plasma products and technology for the Chinese market for US$290 million, subject to certain adjustments.

Pre-CAAP company Iris Technologies has developed screen technology to allow people suffering from post-concussion symptoms to read with less pain/fatigue. This news story on CTV features the results of a study from Toronto Western Hospital.

Check out what's coming up this month at JLABS

The Centre for Aging + Brain Health Innovation (CABHI) announced today the second round of funding available through its Industry Innovation Partnership Program (I2P2). This program is designed to enable successful applicant companies worldwide to accelerate the evaluation and adoption of their innovative products and services that can help to address the needs of aging adults. In total, up to $3 million CAD in funding will be available for solution testing and validation. 

Scott Moffitt, Managing Director of BioNova, the host of BIC, announced the semi-finalists, which included Tieos Pharmaceuticals. All semi-finalists will receive professional pitch training between now and the semi-final run off, which will be held in Halifax on October 17.

VANCOUVER, BC, August 17, 2017. Reliq Health Technologies Inc. a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community‐Based Healthcare, is pleased to announce the golive of remote patient monitoring, care coordination and telemedicine platform with their Rio Grande Valley Health Alliance in McAllen, Texas.

TORONTO and CAMBRIDGE, Mass., Aug. 17, 2017. BlueRock Therapeutics, which is developing cell-based therapies designed to alter the course of degenerative disease, today announces the expansion of the company's presence in Toronto with a research, development and manufacturing site in the MaRS Discovery District.

The Consulate General of Canada in Boston and MassMEDIC invite emerging Canadian medtech companies to apply to participate in Canadian Mission to MassMEDIC’s MedTech Showcase, on October 26-27, 2017.

Sernova Corp, a leading clinical stage regenerative medicine company, announced that FronTier Merchant Capital Group will provide North American investor relations (IR) and strategic marketing for Sernova with a goal of increasing market awareness through financial market communications.

A new study conducted bythe Canadian Concussion Centre and Dr. Charles Tator has shown that Iris Technologies' Non-LCD E-Paper Technology can decrease the risk of exacerbating symptoms in sufferers of post-concussion syndrome (PCS).

US FDA unveiled its Digital Health Innovation Action Plan last week, including a Software Pre-Certification Pilot Program to facilitate faster market access for digital health products.

BIO Investor Forum, an international biotech investor conference focused on early and established private companies, is now accepting applications to present at the October 17-18, 2017 event in San Francisco.

In partnership with Global Affairs Canada, Ontario's Ministry of International Trade is organizing a Health Trade Mission to Japan and Korea, targeting business opportunities in these two important markets.

Jumpstarter is a first-of-its-kind startup event that unites and empowers Hong Kong’s hottest startup sectors.

OBIO member company Steadiwear Inc. took home the titles of "Most Innovative Start-up” in the Wearables/IOT/EduTech  Pitch Competition, and the “Most Favorable Startup”, as decided by audience votes, which earned them a spot in the Grand Finale.

Intronix Technologies will be launching "Myoguide DOC", a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient's spasticity and pain.